Skip to content

Clinical trials

Phase 2/3 Heart Failure trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Phase 2/3 Clear all

83 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20035
20043
20055
20065
20076
20083
20096
20101
20118
20123
20134
20145
20153
20166
20183
20203
20214
20221
20233
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed44
Unknown status20
Terminated10
Recruiting4
Suspended2
Withdrawn2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boston Scientific Corporation7
Hebei Medical University4
Ethicare GmbH3
Hospital de Clinicas de Porto Alegre3
Columbia University2
Guy's and St Thomas' NHS Foundation Trust2
Hospital Ana Nery2
Instituto de Cardiologia do Rio Grande do Sul2
Ottawa Heart Institute Research Corporation2
VA Office of Research and Development2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure83
Cardiomyopathy, Dilated5
Coronary Artery Disease4
Diabetes Mellitus4
Heart Diseases4
Cardiomyopathies3
Heart Defects, Congenital3
Inflammation3
Myocardial Infarction3
Myocardial Ischemia3

Trials

Showing 51 to 75 of 83. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.